Press

Filter
Date
Clinician Scientist Professorships

Vier neue Else Kröner Clinician Scientist Professuren ermöglichen Spitzenmedizin bei Krebs-, Nieren- und kardiometabolischen Erkrankungen

EKFS verbindet in Stiftungsprofessuren hochkarätige Forschung und Patientenversorgung von vier Ärztinnen und Ärzten

Image

Reentry after parental leave or supervisory care phase made easier

Else Kröner Clinician Scientist Return-To-Work Grants support medical doctors when returning to the clinical and research sectors after a family-related time-out

Image

Emergency medical relief for Ukraine scaled up by more than a million euros

Else Kröner-Fresenius-Stiftung uses simplified application process to support non-profit organizations

Else Kröner Schools for Medical Scientists

Research in natural sciences and interdisciplinary cooperation in medicine receive funding

Grants to Else Kröner Schools for Medical Scientists amounting to 3.3 million euros awarded in the areas of immunology, genomics and inflammation.

Dr. Sybelle Goedicke-Fritz forscht in der Klinik für Kinder- und Jugendmedizin am Universitätsklinikum des Saarlandes daran, Krankheiten am Geruch zu erkennen.

Berührungsfreie Diagnose soll Krankheiten am Geruch erkennen

Krankheiten wie Mukoviszidose oder Covid am Geruch zu erkennen, ohne Blut abzunehmen, ohne Abstrich und ohne jede Art von Berührung

Dr. Ana Lucía Asturias: Pediatric ophthalmologist, coordinator of the retinopathy of prematurity program

Medical doctor develops program to treat retinopathy of prematurity (ROP) in Guatemala

Dr. Ana Lucía Asturias is being honored with the Else Kröner Fresenius Award for Development Cooperation in Medicine 2024

Saxon State Minister Conrad Clemens opened the conference

Innovation and networking

Conference on Artificial Intelligence and Microelectronics in Medicine opened in Dresden

Publication Prizes

Salute to cutting-edge research: EKFS awards Publication Prizes 2024

New approaches to diagnostics and therapy for cancer, as well as for neuro-degenerative and rare diseases

Impfstoffentwicklung

Neue Studie untersucht Peptid-Impfstoff gegen Akute Myeloische Leukämie

Teilnehmen können Patientinnen und Patienten ab 18 Jahren